Tongkat Ali vs Ashwagandha for Men: What Each One Is Actually Evidenced For

Head to head: what each one is actually evidenced for

Comparison tables are everywhere for this pairing. Almost none carry a number. Below, every cell is tied to a named trial or review.

	Tongkat Ali (Eurycoma longifolia)	Ashwagandha (Withania somnifera)
Best-evidenced use	Total testosterone in men starting from a low baseline; stress-hormone and mood markers	Perceived stress and serum cortisol; sleep quality
Trial dose range	100–400 mg/day of standardised root extract in the main trials (100–600 mg across the full pooled set); 200 mg/day is the most frequently used	300 mg twice daily (600 mg/day) of a full-spectrum root extract in the stress trial; 21 mg/day of withanolide glycosides in the hormone trial
Typical trial duration	4 to 12 weeks	8 weeks to 60 days
Effect size where measured	Pooled SMD 1.352 (95% CI 0.565–2.138, p = 0.001) for total testosterone across 5 RCTs (Leisegang K et al., Medicina 2022;58(8):1047). At 200 mg/day for 4 weeks: salivary cortisol −16%, salivary testosterone +37%, Tension −11%, Anger −12%, Confusion −15% (Talbott SM et al., J Int Soc Sports Nutr 2013;10:28)	Serum cortisol significantly lower than placebo (p = 0.0006) and all stress scales improved (p < 0.0001) in 64 adults over 60 days (Chandrasekhar K et al., 2012). Sleep SMD −0.59 (95% CI −0.75 to −0.42) across 5 RCTs and 400 participants (Cheah KL et al., PLoS One 2021). Salivary testosterone +14.7% versus placebo (p = .010) and DHEA-S +18% (p = .005) in 57 overweight men aged 40–70 (Lopresti AL et al., 2019)
Evidence quality	Meta-analysed, a genuine advantage — but on 5 small trials with very high heterogeneity (I² = 87.3%). On subgroup analysis the effect was significant in hypogonadal men and not significant in healthy men	More trials overall plus a sleep meta-analysis. The testosterone finding rests on one small crossover trial, in salivary rather than serum hormones, which found no significant difference in fatigue, vigour or sexual well-being
Known cautions	NIH LiverTox likelihood score D — possible rare cause of clinically apparent liver injury. LiverTox also notes long-term use and higher doses have not been assessed in humans, and there is no standardisation of purity and concentration across extracts	NIH LiverTox likelihood score B — likely cause of clinically apparent liver injury, with roughly 23 published cases, onset typically 2 to 12 weeks, usually cholestatic or mixed, mostly mild and self-limited but with rare severe cases reported

Tongkat Ali: a pooled effect size, but read the subgroup analysis

Tongkat Ali has something almost no other men's botanical has: a formal meta-analysis of randomised controlled trials with a testosterone endpoint. Leisegang and colleagues reviewed nine studies, pooled five, and reported a standardised mean difference of 1.352 (95% CI 0.565–2.138, p = 0.001).

By convention an SMD of 0.8 is a large effect, so 1.352 reads as substantial. Two details keep it honest. The confidence interval is wide, which is what happens when you pool five small trials. And the reported heterogeneity was I² = 87.3%, meaning the trials disagreed with each other considerably. Most importantly, when the authors split the data by population, the improvement was significant in hypogonadal men and not significant in healthy men.

That subgroup result is the most useful sentence in the Tongkat Ali literature and it is almost never quoted on vendor pages. The effect appears where there is room for it. A man with normal levels should not expect the headline number.

The other well-known trial, Talbott and colleagues in 2013, gave 63 moderately stressed adults 200 mg a day of a standardised water extract for four weeks. These were salivary measures over a short window in a mixed-sex sample — a real result, but not the weight of serum measurements in a large trial.

Ashwagandha: strongest where men are not looking

Most men buy ashwagandha for testosterone. Its best evidence is elsewhere. The most-cited stress trial, by Chandrasekhar and colleagues in 2012, randomised 64 adults with chronic stress to 300 mg of a high-concentration full-spectrum root extract twice daily — 600 mg a day — or placebo for 60 days. Serum cortisol fell substantially relative to placebo (p = 0.0006) and every stress-assessment scale improved (p < 0.0001).

For sleep there is something better than a single trial. Cheah and colleagues pooled five randomised controlled trials in 400 participants in PLoS One in 2021 and found a small but significant improvement in overall sleep: SMD −0.59 (95% CI −0.75 to −0.42).

The testosterone claim is weaker than its reputation. Lopresti and colleagues ran a crossover trial in overweight men aged 40 to 70 with mild fatigue; 57 enrolled, 43 completed all 16 weeks. Salivary testosterone rose 14.7% more than placebo (p = .010) and DHEA-S 18% more (p = .005). But the same paper reports no significant between-group differences in cortisol, estradiol, fatigue, vigour or sexual well-being. One hormone marker moved; the things a man would actually notice did not.

Match the goal to the evidence

The comparison only becomes a decision once you name the goal.

If your goal is…	Better-evidenced option	What was actually measured	The caveat
Raising total testosterone	Tongkat Ali	Pooled SMD 1.352 across 5 RCTs	Significant in hypogonadal men only; not significant in healthy men on subgroup analysis
Lowering perceived stress and cortisol	Ashwagandha	Serum cortisol and validated stress scales over 60 days at 600 mg/day	One trial, 64 participants, and a general-adult rather than male-specific sample
Improving sleep	Ashwagandha	Sleep SMD −0.59 across 5 RCTs and 400 people	The pooled effect is small, and the reviewers noted limited data on serious adverse effects
Improving mood markers under stress	Either — both have data	Tongkat Ali: Tension −11%, Anger −12%, Confusion −15% at 4 weeks. Ashwagandha: all stress scales improved at 60 days	Short trials, self-reported scales
Feeling less tired or more capable	Neither has convincing data	The ashwagandha hormone trial measured fatigue, vigour and sexual well-being	No significant between-group difference on any of the three
Doing something about a diagnosed condition	Neither	These are dietary supplements, not treatments	Clinically low testosterone needs a clinician, not a capsule

Can you take Tongkat Ali and ashwagandha together?

Here is the answer nobody else on this results page gives you: no randomised trial has ever tested the combination. Every effect size quoted above comes from a trial of a single botanical against placebo.

The line you will read repeatedly — "there is no recorded evidence of harm from combining them" — is technically true and close to meaningless. Nobody has looked. Absence of reported harm from an untested combination is an absence of data, not evidence of safety.

There is also a specific reason for caution rather than a generic one. NIH LiverTox, the reference clinicians use, assigns ashwagandha a likelihood score of B — a likely cause of clinically apparent liver injury — based on roughly 23 published cases, onset typically 2 to 12 weeks, predominantly cholestatic or mixed. Most were mild-to-moderate and self-limited, but rare fatal cases and cases requiring transplantation have been reported. Tongkat Ali carries a lower score of D, a possible rare cause, with the reported cases largely in young male bodybuilders where unacknowledged anabolic steroid use weakens the attribution.

Neither score is cause for panic. Both are reasons to read labels and raise it with a clinician if you take medication or have any liver concern.

What the evidence does not show

• Neither is a treatment. Neither botanical has been shown to treat erectile dysfunction or clinically low testosterone. Persistent symptoms deserve a diagnosis.
• Neither has long-term data. The trials cited here run 4 to 16 weeks. What happens over years is unstudied for both.
• Hormone markers are not outcomes. The ashwagandha crossover trial is the clearest demonstration: testosterone moved, and fatigue, vigour and sexual well-being did not.
• Extracts are not interchangeable. Both literatures rest on specific standardised extracts. A label naming the herb but not the standardisation is not automatically the product that was trialled.
• Some popular claims were dropped. Weight-loss, BMI and immune-cell claims for Tongkat Ali circulate on vendor blogs; we could not trace them to a primary human trial, so they are not here.
• There is no head-to-head trial. No study has randomised men to Tongkat Ali versus ashwagandha. This article compares two separate literatures — the best available approach, and still an indirect one.

For the evidence on the three botanicals in that formula, see our pillar review of Tongkat Ali and Tribulus. To judge the category rather than one pairing, the ingredient-by-ingredient verdict matrix grades nine testosterone-booster ingredients against their human trial data.

Frequently asked questions